Drug Database
Back to search

Netherlands · NL-b007ea804af0

Abatixent 2,5 mg filmomhulde tabletten

A apixaban product containing apixaban, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 15 of our countries.

ATC B01AF02

Checked against CBG-MEB (Netherlands) on

Compare price across countriesPer daily dose · free accountAsk the assistant about apixabanAnswers with sources · free accountCheck interactionsScreen a medication list · Growth plan

Where it is registered

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice

Countries holding a registration under ATC B01AF02. Markets marked price are the ones where we can also compare cost per daily dose — open the comparison with a free account.

At a glance

Active substance
APIXABAN
Manufacturer
Sandoz B.V.
Country
Netherlands (NL)
ATC code
B01AF02
ATC class
Apixaban
Defined daily dose
10 mg, O
Dispensing
—
Reimbursed
No
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    125876

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class, other countries

Other records under ATC B01AF02 — apixaban.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3f6835d1-7db1-4d40-a118-38efca7c78a0
GET /v1/drugs/3f6835d1-7db1-4d40-a118-38efca7c78a0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h125876_smpc_en.pdf",
  "strength": null,
  "atc_label": "Apixaban",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg125876",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "APIXABAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h125876_piluk.pdf",
  "authorised_at": "2021/09/24",
  "procedure_number": "NL/H/5036/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "125876",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

Keep going

See everything about apixaban

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction checking is on the Growth plan. No card, nothing to install.

Try it freeOpen in the console